|
[1]
|
Our World in Data. Coronavirus (COVID-19) Vaccinations. https://ourworldindata.org/covid-vaccinations. [2022-3-26].https://ourworldindata.org/covid-vaccinations |
|
[2]
|
National Health Commission of China. Protocol for prevention and control of COVID-19 in China (Edition8). http://www.nhc.gov.cn/xcs/zhengcwj/202105/6f1e8ec6c4a540d99fafef52fc86d0f8.shtml. [2022-3-26]. (In Chinese). http://www.nhc.gov.cn/xcs/zhengcwj/202105/6f1e8ec6c4a540d99fafef52fc86d0f8.shtml |
|
[3]
|
Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA 2021;326(20):2043 − 54. http://dx.doi.org/10.1001/jama.2021.19499CrossRef
|
|
[4]
|
Li Ka Shing Faculty of Medicine, The University of Hong Kong. Forward planning after HK’s fifth wave of Omicron BA.2. http://www.med.hku.hk/zh-HK/news/press/20220322-updates-on-modelling-the-omicron-fifth-wave. [2022-3-26].http://www.med.hku.hk/zh-HK/news/press/20220322-updates-on-modelling-the-omicron-fifth-wave |
|
[5]
|
Nemet I, Kliker L, Lustig Y, Zuckerman N, Erster O, Cohen C, et al. Third BNT162b2 vaccination neutralization of SARS-CoV-2 omicron infection. N Engl J Med 2022;386(5):492 − 4. http://dx.doi.org/10.1056/NEJMc2119358CrossRef
|
|
[6]
|
Collie S, Champion J, Moultrie H, Bekker LG, Gray G. Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa. N Engl J Med 2022;386(5):494 − 496. http://dx.doi.org/10.1056/NEJMc2119270CrossRef
|
|
[7]
|
Johnson AG, Amin AB, Ail AR, Hoots B, Cadwell BL, Arora S, et al. COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of delta and omicron variant emergence—25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71(4):132−8. http://dx.doi.org/10.15585/mmwr.mm7104e2.http://dx.doi.org/10.15585/mmwr.mm7104e2 |